Mangalam Drugs (India) Market Value
| MANGALAM | 106.52 0.50 0.47% |
| Symbol | Mangalam |
Mangalam Drugs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mangalam Drugs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mangalam Drugs.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Mangalam Drugs on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Mangalam Drugs And or generate 0.0% return on investment in Mangalam Drugs over 30 days. Mangalam Drugs is related to or competes with Kingfa Science, Rico Auto, GACM Technologies, COSMO FIRST, Tribhovandas Bhimji, Parag Milk, and Heubach Colorants. Mangalam Drugs is entity of India. It is traded as Stock on NSE exchange. More
Mangalam Drugs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mangalam Drugs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mangalam Drugs And upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 11.3 | |||
| Value At Risk | (4.22) | |||
| Potential Upside | 3.87 |
Mangalam Drugs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mangalam Drugs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mangalam Drugs' standard deviation. In reality, there are many statistical measures that can use Mangalam Drugs historical prices to predict the future Mangalam Drugs' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.83) |
Mangalam Drugs And Backtested Returns
Mangalam Drugs And has Sharpe Ratio of -0.16, which conveys that the firm had a -0.16% return per unit of risk over the last 3 months. Mangalam Drugs exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mangalam Drugs' Standard Deviation of 2.24, risk adjusted performance of (0.08), and Mean Deviation of 1.68 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.3, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Mangalam Drugs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Mangalam Drugs is expected to be smaller as well. At this point, Mangalam Drugs And has a negative expected return of -0.33%. Please make sure to verify Mangalam Drugs' maximum drawdown, kurtosis, day median price, as well as the relationship between the potential upside and daily balance of power , to decide if Mangalam Drugs And performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.72 |
Almost perfect reverse predictability
Mangalam Drugs And has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Mangalam Drugs time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mangalam Drugs And price movement. The serial correlation of -0.72 indicates that around 72.0% of current Mangalam Drugs price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.72 | |
| Spearman Rank Test | 0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 1.57 |
Mangalam Drugs And lagged returns against current returns
Autocorrelation, which is Mangalam Drugs stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mangalam Drugs' stock expected returns. We can calculate the autocorrelation of Mangalam Drugs returns to help us make a trade decision. For example, suppose you find that Mangalam Drugs has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mangalam Drugs regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mangalam Drugs stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mangalam Drugs stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mangalam Drugs stock over time.
Current vs Lagged Prices |
| Timeline |
Mangalam Drugs Lagged Returns
When evaluating Mangalam Drugs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mangalam Drugs stock have on its future price. Mangalam Drugs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mangalam Drugs autocorrelation shows the relationship between Mangalam Drugs stock current value and its past values and can show if there is a momentum factor associated with investing in Mangalam Drugs And.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Mangalam Stock
Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.